Dr. Russell is a Professor of Medicine at the University of British Columbia (UBC), a principal investigator in the Centre for Heart Lung Innovation in Vancouver, B.C., the Chief Medical Officer of the British Columbia Clinical Research Infrastructure Network and a member of the UBC and St. Paul’s Hospital Divisions of Critical Care Medicine. Dr. Russell has over 180 peer-review publications and chapters and is on the editorial board of four journals. His research has focused on randomized controlled trials of new therapies for sepsis, septic shock and acute lung injury and translational research examining the role of genetics of the inflammatory response in critically ill patients. Dr. Russell previously co-founded Sirius Genomics to design, implement, analyze, interpret and report the largest multicenter case-matched pharmacogenomics trial in critical care medicine, enrolling more than 11,000 patients to validate pharmacogenomic biomarkers identifying septic patients who respond to treatment. Dr. Russell completed his undergraduate degree in biology and biochemistry at Princeton University, and earned his medical degree from University of Toronto. He completed a residency in internal medicine at Toronto General Hospital and University of Toronto before his fellowship in critical care medicine at University of California, San Francisco.